The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Wound Biologics Market Research Report 2025
Synopsis
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
The global Wound Biologics market was valued at US$ 3940 million in 2023 and is anticipated to reach US$ 5003.5 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
This report aims to provide a comprehensive presentation of the global market for Wound Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wound Biologics.
Report Scope
The Wound Biologics market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wound Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wound Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis
Segment by Type
Biological Skin Substitutes
Enzyme Preparation
Growth Factor
Segment by Application
Hospital
Drugstore
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wound Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wound Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
The global Wound Biologics market was valued at US$ 3940 million in 2023 and is anticipated to reach US$ 5003.5 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
This report aims to provide a comprehensive presentation of the global market for Wound Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wound Biologics.
Report Scope
The Wound Biologics market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wound Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wound Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis
Segment by Type
Biological Skin Substitutes
Enzyme Preparation
Growth Factor
Segment by Application
Hospital
Drugstore
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wound Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wound Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Wound Biologics Market Overview
1.1 Product Overview and Scope of Wound Biologics
1.2 Wound Biologics Segment by Type
1.2.1 Global Wound Biologics Market Value Comparison by Type (2024-2030)
1.2.2 Biological Skin Substitutes
1.2.3 Enzyme Preparation
1.2.4 Growth Factor
1.3 Wound Biologics Segment by Application
1.3.1 Global Wound Biologics Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Others
1.4 Global Wound Biologics Market Size Estimates and Forecasts
1.4.1 Global Wound Biologics Revenue 2019-2030
1.4.2 Global Wound Biologics Sales 2019-2030
1.4.3 Global Wound Biologics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Wound Biologics Market Competition by Manufacturers
2.1 Global Wound Biologics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Wound Biologics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Wound Biologics Average Price by Manufacturers (2019-2024)
2.4 Global Wound Biologics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wound Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wound Biologics, Product Type & Application
2.7 Wound Biologics Market Competitive Situation and Trends
2.7.1 Wound Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Wound Biologics Players Market Share by Revenue
2.7.3 Global Wound Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Wound Biologics Retrospective Market Scenario by Region
3.1 Global Wound Biologics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Wound Biologics Global Wound Biologics Sales by Region: 2019-2030
3.2.1 Global Wound Biologics Sales by Region: 2019-2024
3.2.2 Global Wound Biologics Sales by Region: 2025-2030
3.3 Global Wound Biologics Global Wound Biologics Revenue by Region: 2019-2030
3.3.1 Global Wound Biologics Revenue by Region: 2019-2024
3.3.2 Global Wound Biologics Revenue by Region: 2025-2030
3.4 North America Wound Biologics Market Facts & Figures by Country
3.4.1 North America Wound Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Wound Biologics Sales by Country (2019-2030)
3.4.3 North America Wound Biologics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Wound Biologics Market Facts & Figures by Country
3.5.1 Europe Wound Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Wound Biologics Sales by Country (2019-2030)
3.5.3 Europe Wound Biologics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wound Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Wound Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Wound Biologics Sales by Country (2019-2030)
3.6.3 Asia Pacific Wound Biologics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Wound Biologics Market Facts & Figures by Country
3.7.1 Latin America Wound Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Wound Biologics Sales by Country (2019-2030)
3.7.3 Latin America Wound Biologics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wound Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Wound Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Wound Biologics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Wound Biologics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Wound Biologics Sales by Type (2019-2030)
4.1.1 Global Wound Biologics Sales by Type (2019-2024)
4.1.2 Global Wound Biologics Sales by Type (2025-2030)
4.1.3 Global Wound Biologics Sales Market Share by Type (2019-2030)
4.2 Global Wound Biologics Revenue by Type (2019-2030)
4.2.1 Global Wound Biologics Revenue by Type (2019-2024)
4.2.2 Global Wound Biologics Revenue by Type (2025-2030)
4.2.3 Global Wound Biologics Revenue Market Share by Type (2019-2030)
4.3 Global Wound Biologics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Wound Biologics Sales by Application (2019-2030)
5.1.1 Global Wound Biologics Sales by Application (2019-2024)
5.1.2 Global Wound Biologics Sales by Application (2025-2030)
5.1.3 Global Wound Biologics Sales Market Share by Application (2019-2030)
5.2 Global Wound Biologics Revenue by Application (2019-2030)
5.2.1 Global Wound Biologics Revenue by Application (2019-2024)
5.2.2 Global Wound Biologics Revenue by Application (2025-2030)
5.2.3 Global Wound Biologics Revenue Market Share by Application (2019-2030)
5.3 Global Wound Biologics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Avita Medical
6.1.1 Avita Medical Corporation Information
6.1.2 Avita Medical Description and Business Overview
6.1.3 Avita Medical Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Avita Medical Wound Biologics Product Portfolio
6.1.5 Avita Medical Recent Developments/Updates
6.2 ConvaTec
6.2.1 ConvaTec Corporation Information
6.2.2 ConvaTec Description and Business Overview
6.2.3 ConvaTec Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ConvaTec Wound Biologics Product Portfolio
6.2.5 ConvaTec Recent Developments/Updates
6.3 Acelity
6.3.1 Acelity Corporation Information
6.3.2 Acelity Description and Business Overview
6.3.3 Acelity Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Acelity Wound Biologics Product Portfolio
6.3.5 Acelity Recent Developments/Updates
6.4 Cytori Therapeutic
6.4.1 Cytori Therapeutic Corporation Information
6.4.2 Cytori Therapeutic Description and Business Overview
6.4.3 Cytori Therapeutic Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cytori Therapeutic Wound Biologics Product Portfolio
6.4.5 Cytori Therapeutic Recent Developments/Updates
6.5 MacroCure
6.5.1 MacroCure Corporation Information
6.5.2 MacroCure Description and Business Overview
6.5.3 MacroCure Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MacroCure Wound Biologics Product Portfolio
6.5.5 MacroCure Recent Developments/Updates
6.6 Nuo Therapeutics
6.6.1 Nuo Therapeutics Corporation Information
6.6.2 Nuo Therapeutics Description and Business Overview
6.6.3 Nuo Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nuo Therapeutics Wound Biologics Product Portfolio
6.6.5 Nuo Therapeutics Recent Developments/Updates
6.7 Molyncke Health Care
6.6.1 Molyncke Health Care Corporation Information
6.6.2 Molyncke Health Care Description and Business Overview
6.6.3 Molyncke Health Care Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Molyncke Health Care Wound Biologics Product Portfolio
6.7.5 Molyncke Health Care Recent Developments/Updates
6.8 Osiris Therapeutics
6.8.1 Osiris Therapeutics Corporation Information
6.8.2 Osiris Therapeutics Description and Business Overview
6.8.3 Osiris Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Osiris Therapeutics Wound Biologics Product Portfolio
6.8.5 Osiris Therapeutics Recent Developments/Updates
6.9 Smith And Nephew
6.9.1 Smith And Nephew Corporation Information
6.9.2 Smith And Nephew Description and Business Overview
6.9.3 Smith And Nephew Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Smith And Nephew Wound Biologics Product Portfolio
6.9.5 Smith And Nephew Recent Developments/Updates
6.10 Organogenesis
6.10.1 Organogenesis Corporation Information
6.10.2 Organogenesis Description and Business Overview
6.10.3 Organogenesis Wound Biologics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Organogenesis Wound Biologics Product Portfolio
6.10.5 Organogenesis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wound Biologics Industry Chain Analysis
7.2 Wound Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wound Biologics Production Mode & Process
7.4 Wound Biologics Sales and Marketing
7.4.1 Wound Biologics Sales Channels
7.4.2 Wound Biologics Distributors
7.5 Wound Biologics Customers
8 Wound Biologics Market Dynamics
8.1 Wound Biologics Industry Trends
8.2 Wound Biologics Market Drivers
8.3 Wound Biologics Market Challenges
8.4 Wound Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
